We are Main Street
World

Tate & Lyle Volumes Rise as Profit Falls

Food makers buying sweeteners and starches should expect continued cost pass-through as the company trades price for volume.

Updated on Nov. 5, 2026 in Corporate Finance

Row of weathered stainless-steel storage silos beside a processing building, with a conveyor line and white granular material spilling from a chute under overcast daylight.
Tate & Lyle reported first-half revenue up 1% to £1bn on a 3% volume rise after price cuts, while EBITDA fell 8%, as Ingredion's pending acquisition advances. AI Illustration. Upload story photo >

Tate & Lyle reported first-half revenue growth of 1% to £1bn, led by a 3% rise in volumes after price cuts, while EBITDA fell 8% to £197m. The company is also in the process of being acquired by US rival Ingredion, a deal shareholders approved on 28 July 2026.

Why it matters

The results show a food-ingredients supplier trading volume for top-line growth at the cost of profit, with price cuts driving the volume gains. Companies that buy or sell sweeteners, starches and bio-gums should watch how cost pass-through and a pending ownership change reshape supply terms.

Tate & Lyle's first-half revenue rose 1% to £1bn while EBITDA fell 8% to £197m, with volumes up 3%. The company has achieved $27m of savings under a $200m five-year productivity programme, and expects a one-off $10m charge from consolidating bio-gums manufacturing.

The players

Tate & Lyle

A global specialty food and ingredients company whose sweeteners, starches and fibres serve food and beverage manufacturers worldwide.

Ingredion

A US-based ingredients maker specialising in starches, sweeteners and texturants that supply the food and beverage industry.

The details

Revenue growth came from volume gains of 3%, which followed price cuts the company made during the first half. Because the price reductions weighed on margins, EBITDA declined even as sales rose. To offset cost pressure, Tate & Lyle is running a $200m five-year productivity programme, and it has already delivered $27m of savings in the half to 30 September 2026. The company also warned that it will pass through more costs than it had anticipated as the Iran war drags on.

Timeline

  1. 28 July 2026: Shareholders approved the acquisition by Ingredion.

  2. 30 September 2026: End of the half-year period in which $27m of savings were achieved.

  3. 5 November 2026: Half-year results published.

Market Landscape

The results arrive as Tate & Lyle moves toward being acquired by US rival Ingredion, a consolidation step shareholders approved on 28 July 2026. The company's volume-for-price trade-off and its cost-cutting programme show how specialty ingredient makers are defending their positions in a squeezed market.

Buyers of sweeteners and starches should expect cost pass-through to continue as input pressures persist. Businesses that depend on Tate & Lyle or Ingredion should review supply contracts and pricing terms in case the acquisition changes supplier relationships.

The takeaway

Price-led volume growth is not translating into profit at this producer, so margin trends are the figure to watch. Procurement teams should track whether the company's cost pass-through and productivity savings hold up in the full-year results.

Further reading

For broader context on how deals and restructuring reshape company financials, explore our Corporate Finance coverage.